Anonymous
Guest
Anonymous
Guest
ImmuKnow is a biomarker of immune function that complements immunomodulatory therapy and helps physicians and other healthcare professionals more effectively manage immunosuppression in posttransplant patients, thereby reducing the risks of infection and rejection by:
Providing a global marker of immune function and response to immunosuppression at the cellular level Detecting changes in CD4 cell ATP production Helping to define a range of stable immune function for each patient Providing critical, actionable information on an ongoing, individual basis when used longitudinally (in combination with other routine monitoring tests)
ImmuKnow is the FDA-cleared assay that tracks changes in global immune function over time.
Providing a global marker of immune function and response to immunosuppression at the cellular level Detecting changes in CD4 cell ATP production Helping to define a range of stable immune function for each patient Providing critical, actionable information on an ongoing, individual basis when used longitudinally (in combination with other routine monitoring tests)
ImmuKnow is the FDA-cleared assay that tracks changes in global immune function over time.